Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2025-12-25 @ 2:31 AM
NCT ID:
NCT05990634
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with malignant melanoma (stage I-III) and undergone primary treatment within the last 36 months.
* Has completed primary and secondary cancer treatment and is now in remission (survivorship stage).
* Assessed as physically and mentally able to participate in the study
* Can read, write and understand the Swedish language
* Can bring and use their own smart phone (Android version 10 or newer) below the study
* Have 24-hour access to internet (broadband) via WiFi router in your own household and/or free 4G mobile data (sim card and 4G router will be provided if this criterion is not met)
Exclusion Criteria:
* Terminal cancer stage or prognosis \<18 months from time of recruitment
* Diagnosed with severe mental illness or cognitive illness that affects the ability to participate
* Screening with Mini-Cog where the result is between 0-2
* Inability or unwillingness to provide written informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT05990634
Study Brief:
Protocol Section:
NCT05990634